Skip to content

Confocal Laser Micro-endoscopy in Chronic Obstructive Pulmonary Disease (COPD) and Lung Transplant Recipients

Confocal Laser Micro-endoscopy: New Insights in COPD and Lung Transplant Recipients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01204970
Enrollment
176
Registered
2010-09-20
Start date
2010-09-30
Completion date
2016-12-31
Last updated
2016-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease, Lung Transplantation

Keywords

Confocal Laser Scanning Microendoscopy, Small airways, COPD, Lung transplantation

Brief summary

Aspects of confocal laser micro-endoscopy (CLME) and morphometry in chronic obstructive pulmonary disease (COPD) and lung transplant recipients is described and will be correlated with clinical findings in order to described small airway remodelling in these patients.

Detailed description

In early phases of COPD, changes in small airway characteristics may develop. Elastin decay and matrix remodelling could be responsible for these changes. Using CLME changes of in the bronchiolar wall and alveolar ducts can be visualized, described and measured. In lung transplant recipients, CMLE will be performed to distinguish characteristics of distal airways in stabile patient in contrast to patients with bronchiolitis obliterans syndrome. In both groups data will be correlated with CT findings, pulmonary function tests and anatomopathological results.

Interventions

None listed

Sponsors

KU Leuven
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* referral for bronchoscopic investigation/sampling * informed consent signed * recent spirometric data

Exclusion criteria

* sedated and/or ventilated patients * patients on ICU * patients under oral anticoagulation * co-existing lung disease * acute infectious pulmonary disease

Design outcomes

Primary

MeasureTime frameDescription
morphometry90 - 180 - 360 - 540 - 720 daysmorpohometrical analysis at different time point after lung transplantation

Secondary

MeasureTime frameDescription
adverse events90 - 180 - 360- 540- 720 daysbleeding, pneumothorax, pleuritic chest pain during procedure

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026